Hepatic Cirrhosis
📧 Sign up to get email alerts when something new happens for Hepatic Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites [Phase 3]
A Phase III clinical trial evaluating tolvaptan tablets for treating ascites due to hepatic cirrhosis has completed.
-
FDA approval · 2012-09-26FDA Approved: TORSEMIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals, Inc.'s supplemental application for torsemide, authorizing a modification to the torsemide product unde…
-
FDA approval · 2012-09-26FDA Approved: TORSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for torsemide from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2012-09-18FDA Approved: TORSEMIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for torsemide from Rising Pharma Holdings, Inc., indicating regulatory approval of changes to the to…
-
FDA approval · 2012-03-27FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for LASIX (furosemide) submitted by Validus Pharmaceuticals LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-12-31FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare U.S., LLC)
FDA approves Solco Healthcare U.S., LLC's supplemental application for hydrochlorothiazide, enabling continued supply of the generic diureti…
-
FDA approval · 2011-09-22FDA Approved: TORSEMIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA issued a supplemental approval for Torsemide from Rising Pharma Holdings, approving a generic torsemide product.
-
FDA approval · 2011-09-21FDA Approved: TORSEMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for torsemide from Teva Pharmaceuticals USA, Inc. This approval pertains to a supplemental submissio…
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis [Phase 1]
Phase 1 multiple-dose pharmacokinetics study of tolvaptan tablets conducted in Chinese patients with hepatic cirrhosis and ascites; the tria…
-
FDA approval · 2011-01-26FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for furosemide, a generic diuretic, under the existing ANDA.
-
FDA approval · 2010-09-28FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for torsemide submitted by Chartwell RX, LLC under ANDA 076894. The action approves changes to t…
-
CLINICAL_TRIALS trial_result · 2010-08-09Clinical Trial Update: Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With Cirrhosis [Phase 1]
This Phase 1 study evaluated the reproducibility of the Child-Turcotte-Pugh rating and the pharmacokinetics of NRL972 in patients with hepat…
-
FDA approval · 2010-03-08FDA Approved: BUMETANIDE — Supplemental Application (Sagent Pharmaceuticals)
The FDA approved a supplemental application for Bumetanide submitted by Sagent Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment [Phase 3]
Phase 3 trial evaluating long-term interferon for patients with hepatitis C who did not clear the virus with standard treatment; study compl…
-
FDA approval · 2009-05-04FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin [Phase 1]
This Phase 1 pharmacokinetic study evaluated NRL972 when administered with ursodeoxycholic acid and cloxacillin in individuals with hepatic …
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers [Phase 1, Phase 2]
Clinical trial update reports Phase 1 and Phase 2 results for the clearance of NRL972 in patients with hepatic cirrhosis and nonalcoholic st…
-
FDA approval · 2009-01-30FDA Approved: AMILORIDE HYDROCHLORIDE — Original Application (Sigmapharm Laboratories, LLC)
FDA approves Sigmapharm Laboratories, LLC's amiloride hydrochloride as an original generic application (ANDA) product space.
-
FDA approval · 2009-01-27FDA Approved: TORSEMIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic torsemide (Original Application), authorizing the generic torsemide tablet for edema associated…
-
FDA approval · 2008-10-22FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for LASIX (furosemide) from Validus Pharmaceuticals LLC.
-
FDA approval · 2008-05-09FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for torsemide by Chartwell RX, LLC, updating an approved generic product (ANDA).
-
FDA approval · 2008-04-30FDA Approved: BUMETANIDE — Original Application (Civica, Inc.)
FDA approved Civica, Inc.'s original application for bumetanide, authorizing a generic version of the diuretic bumetanide.
-
FDA approval · 2007-11-07FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for torsemide from Chartwell RX, LLC, updating the label for this generic diuretic.
-
FDA approval · 2007-10-17FDA Approved: TORSEMIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original Abbreviated New Drug Application for torsemide from Rising Pharma Holdings, granting regulatory clearance for a ge…
-
FDA approval · 2007-10-03FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Torsemide from Chartwell RX, LLC.